Stromal vascular fraction technologies and clinical applications

Area of Science:

• Regenerative Medicine
• Cellular Therapy
• Adipose Tissue Biology

Background:

• The stromal vascular fraction (SVF) and adipose-derived stem cells (ASCs) are key components in regenerative medicine.
• SVF and ASCs possess distinct properties necessitating tailored clinical applications.
• Current literature highlights the growing use of SVF and ASCs in therapeutic strategies.

Purpose of the Study:

• To review the clinical applications of SVF, differentiating it from ASCs.
• To identify primary medical fields for SVF development based on existing literature.
• To appraise the safety and benefits of SVF in various clinical contexts.

Main Methods:

• Literature review focusing on the clinical use of SVF.
• Analysis of 71 clinical studies investigating SVF safety and benefits.
• Examination of methods for SVF isolation, including enzymatic digestion and mechanical disruption.

Main Results:

• SVF has been investigated in 71 clinical studies for musculoskeletal, wound healing, urogenital, cardiovascular, and respiratory diseases.
• The therapeutic application of SVF is largely experimental, with limited clinical trials.
• SVF demonstrates potential in enhancing angiogenesis and neovascularization, and in immune-modulation for joint conditions.

Conclusions:

• SVF and ASCs require distinct therapeutic approaches based on clinical indications.
• SVF holds promise for treating various conditions through its microenvironment regulation, angiogenesis promotion, and anti-inflammatory effects.
• Emerging point-of-care technologies aim to refine SVF for regulatory compliance and minimal manipulation.